Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post exposure prevention

    Project Inform Perspective
    |May 30, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Post Exposure Prevention (PEP) is a short course of anti-HIV drugs taken soon after a potential HIV exposure. PEP aims to block HIV from establishing infection in the body.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Everything antiretroviral: 5th IAS conference, Cape Town, South Africa.

    Project Inform perspective·2012
    Same journal

    Well implemented, President Obama's national HIV/AIDS strategy is precisely what is needed to further control HIV/AIDS.

    Project Inform perspective·2011
    Same journal

    Finding health care; preparing for the future.

    Project Inform perspective·2011
    Same journal

    Protecting people with HIV in the California budget.

    Project Inform perspective·2010
    Same journal

    Current drugs in clinical study.

    Project Inform perspective·2010
    Same journal

    HIV treatment information.

    Project Inform perspective·2010
    See all related articles

    Area of Science:

    • Virology
    • Public Health
    • Pharmacology

    Background:

    • Growing interest in Post Exposure Prevention (PEP) for HIV infection.
    • PEP involves initiating anti-HIV therapy shortly after suspected exposure.
    • The primary goal of PEP is to prevent HIV establishment.

    Discussion:

    • Effectiveness of early intervention in blocking viral replication.
    • The critical time window for initiating PEP.
    • The role of antiretroviral therapy in post-exposure prophylaxis.

    Key Insights:

    • PEP is a viable strategy for HIV prevention.
    • Timeliness of treatment is crucial for PEP efficacy.
    • PEP offers a proactive approach to managing HIV exposure risks.

    Outlook:

    • Further research into optimizing PEP protocols.
    • Expanding access to PEP services globally.
    • Integration of PEP into comprehensive HIV prevention strategies.